Joe Rogan's Guest Reveals Big Pharma Lobbying Against 'Dangerous' Chinese Peptides While Signing a $7 Billion Deal To Acquire A Chinese Peptide Company
During JRE episode #2469, Brigham Buhler—a healthcare entrepreneur—described a contradiction at the heart of Eli Lilly’s lobbying against compounded peptides. As Buhler told it, Eli Lilly was publicly…
calfkicker.com